The trial, conducted at RDC Clinical in Brisbane, Australia, between July and December 2025, was prospectively registered with ClinicalTrials.gov and approved by an independent ethics committee. Participants were randomly allocated in a one-to-one ratio to receive either the active softgel capsules or an identical placebo containing only sunflower oil. The active capsules delivered 28 to 30 milligrams of mixed carotenoids daily, a blend of lutein, zeaxanthin, alpha-carotene, beta-carotene, and lycopene, the same pigments that give carrots, tomatoes, and leafy greens their vivid colors. Investigators, participants, and even the statistician analyzing the data remained blinded to group assignments throughout, and compliance was impressively high, averaging near or above the full prescribed dose in both arms.

The scientific rationale for the study rests on decades of work showing that carotenoids are among the skin’s most important dietary allies. Skin aging unfolds through two overlapping pathways: intrinsic aging, driven by genetics, metabolism, and hormonal shifts, and extrinsic aging, driven by ultraviolet radiation, smoking, and pollution. Both converge on the production of reactive oxygen species, unstable molecules that damage proteins, lipids, and DNA, degrading the collagen and elastic fibers that keep skin firm and resilient. Carotenoids counter this assault in two ways, directly neutralizing free radicals and switching on the body’s own antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. When ingested, they accumulate in the skin, where they also absorb specific wavelengths of ultraviolet light and dissipate the energy as harmless heat, providing a form of internal photoprotection.

The timing of the intervention was no accident. Women in their forties and fifties face a particularly punishing hormonal transition for their skin. Estrogen normally stimulates fibroblasts to produce collagen and promotes hyaluronic acid synthesis, which locks moisture into the tissue and limits water escaping through the surface. As estrogen declines through perimenopause and menopause, collagen production falters while its breakdown accelerates; skin collagen is estimated to fall by roughly thirty percent during the first five years of menopause, and a further two percent each year afterward. The result is thinning, dryness, and a weakening of the skin barrier, precisely the deficits the Brisbane team set out to measure with objective instruments rather than subjective impressions.

Those instruments were put to work at baseline, week six, and week twelve. A high-resolution imaging system, the A-One Smart Pro, photographed each participant’s face under normal, ultraviolet, and polarized lighting, using algorithms to score wrinkles, elasticity, moisture, sebum, pigmentation, pore size, and temperature. A separate DermaLab Combo system measured transepidermal water loss, or TEWL, the gold-standard indicator of skin barrier function, and used high-frequency ultrasound to gauge dermal thickness. Meanwhile, a non-invasive spectroscopy device called the Veggie Meter quantified the carotenoids actually present in each participant’s skin, providing a direct readout of whether the supplement was reaching its target tissue.

The headline result was a striking negative. At both week six and week twelve, there were no significant differences between the active and placebo groups on any of the visible aging parameters, meaning the supplement did not visibly smooth wrinkles, tighten pores, or brighten pigmentation over the study period. One unexpected wrinkle in the data even favored placebo: the control group showed a larger improvement in elasticity scores over time. The researchers acknowledge that the trial may have been underpowered for visible outcomes, since their sample size calculation was based on effect estimates drawn from a physiologically different study of eye health, an acknowledged limitation that introduces uncertainty into the power analysis.

Beneath the surface, however, the story changed dramatically. Skin carotenoid scores in the supplement group surged by 48.1 percent from baseline, rising significantly by week six and widening further by week twelve, while the placebo group remained essentially flat. Because dietary carotenoid intake, tracked with a validated questionnaire, was similar in both groups, the increase clearly reflected the bioavailability of the capsules themselves, which the lipophilic compounds carried alongside sunflower oil. This matters because only an estimated five to thirty percent of dietary carotenoids are typically absorbed, and the rapid enrichment of skin tissue validates both the formulation and the delivery system.

Two structural markers also moved in the right direction. Transepidermal water loss, which rises when the skin barrier leaks moisture, fell by 31.3 percent from baseline in the supplement group, a change that was statistically significant compared with placebo and supported by a repeated-measures analysis showing an overall treatment effect. Dermal thickness, measured by ultrasound, increased by 11.9 percent in the active group versus 3.6 percent with placebo, a between-group difference in change that also reached significance. The authors suggest that the reduced water loss may stem from carotenoid protection of lipid membranes in the stratum corneum, while the thickening dermis points toward enhanced collagen deposition in the extracellular matrix, since carotenoids such as beta-carotene, lutein, and lycopene have been shown to protect collagen from oxidative degradation and to support its synthesis.

The safety profile was reassuring. Thirteen adverse events were reported across the study, most of them mild, self-limiting gastrointestinal complaints such as bloating, reflux, and loose stools, with similar rates in both groups. There were no serious adverse events and no withdrawals attributed to the treatment, and the harmless skin yellowing known as carotenoderma, a theoretical concern with high carotenoid intakes, did not appear. The researchers caution that whether the 31.3 percent reduction in water loss translates into perceptible relief from dryness cannot be confirmed, because the trial included no patient-reported outcome measures of skin comfort, and that the structural changes detected on ultrasound had not yet ripened into visible surface improvements within twelve weeks.

What the study ultimately delivers is a biologically grounded, cautiously optimistic case rather than a cosmetic miracle. The authors conclude that CaroRite may support antioxidant status, barrier function, and dermal structure, key parameters for long-term skin health that can precede detectable changes in visible aging, and they call for longer trials, alternative doses, combination formulations, and populations with more advanced photoaging, as well as men and older adults excluded from this study. For consumers tempted by the promise of a wrinkle-free capsule, the message is tempered: twelve weeks of carotenoids made these women’s skin measurably healthier under the hood, but erasing the lines etched by decades of time, gravity, and sunlight remains a far slower and harder project than nourishing the living tissue underneath.

Subject of Research: Effects of oral mixed-carotenoid supplementation on skin health and visible signs of aging in healthy middle-aged women

Article Title: CaroRite™ for improving skin health and the visible signs of aging – a randomised, double-blind, placebo-controlled trial

Article References: CaroRite™ for improving skin health and the visible signs of aging – a randomised, double-blind, placebo-controlled trial. (n.d.). https://doi.org/10.3389/fragi.2026.1858090

Image Credits: AI Generated

DOI: 10.3389/fragi.2026.1858090

Keywords: carotenoids, skin aging, CaroRite, transepidermal water loss, dermal thickness, randomized controlled trial, nutricosmetics, skin barrier, lutein, beta-carotene, lycopene, antioxidants